TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options
Clinical trial NCT00115050 · COMPLETED
Trial details
- NCT number
- NCT00115050
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-06-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.